The Thesis
Channel-pullback is a trend-continuation strategy dressed as a dip-buyer. It buys pullbacks to the lower regression channel or volume support — but only inside confirmed uptrends — and exits at the upper channel or resistance. In plain terms: it wants to buy strong names on temporary weakness and sell them into strength, trading a broad 24-name universe of large-cap US equities spanning tech, financials, healthcare, staples, and energy (AAPL, MSFT, NVDA, JPM, JNJ, XOM, and others).
The design implies a low win rate by construction, and the numbers agree: across 137 backtested trades the strategy won just 39.39% of the time. That is workable only if the winners are meaningfully larger than the losers — the classic trend-follower's asymmetry.
Backtest Performance
Over 451 days the strategy grew a $10,000 book to $10,761.52 — a 7.62% total return, or roughly 4.19% CAGR. That headline hides two concerns. First, risk-adjusted return is thin: a Sharpe of 0.40 against a maximum drawdown of 14.83% is not a comfortable ratio. Second, turnover is extreme at 2,311% — the book effectively recycles itself more than twenty times, and while total fees were modest ($137, with no FX cost), that churn is a fragility signal in live conditions.
The Validation Problem
This is where balance matters most: validation did not pass. A four-fold walk-forward test tells a story of inconsistency rather than skill. Three of four folds were positive, but the dispersion is violent — Fold 1 returned +6.53% (Sharpe 1.25), Fold 3 posted a stellar +20.68% (Sharpe 3.86, drawdown of just 3.26%), yet Fold 2 (Jan–Jul 2025) lost 11.42% with a Sharpe of −1.70. The out-of-sample return averaged a modest 3.63% (OOS Sharpe 0.74).
The deflated statistics are the real warning. Across 7 trials, the Probabilistic Sharpe Ratio sits at 0.702, but the Deflated Sharpe Ratio collapses to 0.196. A DSR that low means that, once we account for multiple testing, we cannot confidently distinguish this strategy's edge from luck.
Recent Live Activity
Running live, the paper book stands at roughly $10,961 total, down from about $11,171 a week earlier. Recent scheduled runs show more rejections than executions — several days logged "0 executed" with 1–2 rejected orders, suggesting the entry conditions or cash constraints are frequently gating trades. When it does act, it has been rotating: buying energy and financials (CVX, XOM, BAC) and adding MSFT, while trimming NVDA (twice), HD, and PG.
Verdict
Channel-pullback has a coherent thesis and a positive, if unspectacular, backtest. But the failed validation, low DSR, high turnover, and one badly negative fold mean it should be treated as a candidate under observation — not a proven earner. The rotation into defensives and energy is worth watching; the edge is not yet worth trusting.